CVM - CEL SCI CORP
3.94
-0.060 -1.523%
Share volume: 63,790
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.00
-0.06
-0.02%
View ratios
| Fiscal Date | 12-31-2023 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | |
| Report Date | 02-14-2025 | 08-14-2024 | 02-14-2025 | 02-14-2025 | 05-14-2025 | 08-14-2025 | 02-17-2026 | |
| Assets | ||||||||
| Total Assets | 28.710 M | 24.068 M | 26.992 M | 25.699 M | 21.807 M | 20.336 M | 22.895 M | |
| Current Assets | 6.154 M | 3.542 M | 6.056 M | 5.858 M | 3.023 M | 2.623 M | 7.030 M | |
| Inventories | 2.347 M | 2.555 M | 1.020 M | 863.104 K | 882.692 K | 518.040 K | 230.448 K | |
| Other Current Assets | 16.129 K | 51.129 K | 3.500 K | 7.500 K | 7.500 K | 7.500 K | 7.085 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.241 M | 384.652 K | 4.738 M | 4.614 M | 1.924 M | 1.793 M | 6.278 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 9.644 M | 8.613 M | 8.130 M | 7.593 M | 7.080 M | 6.579 M | 5.571 M | |
| Other Assets | 12.912 M | 11.913 M | 12.806 M | 12.248 M | 11.704 M | 11.135 M | 10.294 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 28.710 M | 24.068 M | 26.992 M | 25.699 M | 21.807 M | 20.336 M | 22.895 M | |
| Total liabilities | 16.060 M | 15.595 M | 14.125 M | 14.390 M | 13.809 M | 13.311 M | 11.756 M | |
| Total current liabilities | 4.867 M | 5.506 M | 4.616 M | 5.480 M | 5.500 M | 5.616 M | 5.041 M | |
| Accounts Payable | 1.144 M | 1.369 M | 1.448 M | 1.999 M | 1.702 M | 1.577 M | 1.035 M | |
| Other liabilities | 1.724 M | 1.611 M | 1.551 M | 1.498 M | 1.462 M | 1.423 M | 1.648 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.724 M | 1.611 M | 1.551 M | 1.498 M | 1.462 M | 1.423 M | 1.648 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.650 M | 8.473 M | 12.867 M | 11.309 M | 7.998 M | 7.025 M | 11.139 M | |
| Common stock | 506.451 M | 516.375 M | 526.879 M | 532.394 M | 535.655 M | 540.347 M | 556.031 M | |
| Retained earnings | -493.801 M | -507.902 M | -514.012 M | -521.085 M | -527.657 M | -533.322 M | -544.892 M |